Gara Jalqabaatti › Lupus
Qorannoo klinikaalii Lupus Ameerikaa Keessatti hirmaatuu
Qorannoo 73 Lupus f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- New York City, NYQorannoo 18
- Houston, TXQorannoo 13
- Durham, NCQorannoo 12
- Miami, FLQorannoo 11
- Washington, DCQorannoo 10
- Tampa, FLQorannoo 9
- Philadelphia, PAQorannoo 9
- Clearwater, FLQorannoo 8
- Santa Monica, CAQorannoo 8
- Oklahoma City, OKQorannoo 8
- Los Angeles, CAQorannoo 8
- Chicago, ILQorannoo 8
- Boston, MAQorannoo 8
- Plantation, FLQorannoo 7
- Memphis, TNQorannoo 7
- San Diego, CAQorannoo 7
- Charlotte, NCQorannoo 7
- Buena Park, CAQorannoo 7
- Dallas, TXQorannoo 6
- Cedar Rapids, IAQorannoo 6
- Hollywood, FLQorannoo 6
- Atlanta, GAQorannoo 6
- Aurora, COQorannoo 6
- Jackson, TNQorannoo 5
- Orlando, FLQorannoo 5
- Fullerton, CAQorannoo 5
- St. Louis, MOQorannoo 5
- Lake Charles, LAQorannoo 5
- Syracuse, NYQorannoo 5
- Cleveland, OHQorannoo 5
- New Orleans, LAQorannoo 5
- Cicero, ILQorannoo 5
- New Rochelle, NYQorannoo 4
- Salt Lake City, UTQorannoo 4
- San Francisco, CAQorannoo 4
- Arlington, TXQorannoo 4
- Flint, MIQorannoo 4
- Frisco, TXQorannoo 4
- Brandon, FLQorannoo 4
- Mesquite, TXQorannoo 4
Naannoon
- AlabamaQorannoo 5
- ArizonaQorannoo 7
- CaliforniaQorannoo 27
- ColoradoQorannoo 8
- Distaarikii KoloombiyaaQorannoo 5
- FloridaQorannoo 23
- GeorgiaQorannoo 9
- IllinoisQorannoo 14
- IndianaQorannoo 4
- IowaQorannoo 6
- KansasQorannoo 5
- KentuckyQorannoo 4
- LouisianaQorannoo 9
- MarylandQorannoo 10
- MassachusettsQorannoo 9
- MichiganQorannoo 10
- MinnesotaQorannoo 5
- MissouriQorannoo 8
- NebraskaQorannoo 3
- New JerseyQorannoo 6
- New YorkQorannoo 26
- North CarolinaQorannoo 20
- OhioQorannoo 11
- OklahomaQorannoo 8
- PennsylvaniaQorannoo 14
- South CarolinaQorannoo 5
- TennesseeQorannoo 13
- TexasQorannoo 26
- UtahQorannoo 4
- VirginiaQorannoo 3
- WashingtonQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06570798Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07260877A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 16 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07409181Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05268289Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 5 hanga 17 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05835310Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Dubartoota · Haaromfame 28-Ful-2026 · NCT05567198A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07607964A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07438496CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 10 hanga 29 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06839976Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07201558The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05440422Anifrolumab Pregnancy Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Dubartoota · Haaromfame 18-Ful-2026 · NCT07049653Transcutaneous Vagus Nerve Stimulation in SLE
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06987565A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 16 hanga 70 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07328581HEALTH Home Urinalysis Testing
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07823478Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 130 · Dubartoota · Haaromfame 16-Ful-2026 · NCT06594068Study of Systemic Lupus Erythematosus
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 3 hanga 120 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT00001372A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06916806A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 70 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07570862Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06975787A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07355218Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.